Literature DB >> 2874788

Exposure in vivo of obsessive-compulsives under distracting and attention-focusing conditions: replication and extension.

J B Grayson, E B Foa, G S Steketee.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 2874788     DOI： 10.1016/0005-7967(86)90013-6

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN： 0005-7967


× No keyword cloud information.
  6 in total

Review 1.  Cognitive behavioral therapy for obsessive-compulsive disorder: an update.

Authors:  Jonathan D Huppert; Martin E Franklin
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

2.  Attenuated neural reactivity to happy faces is associated with rule breaking and social problems in anxious youth.

Authors:  Nora Bunford; Autumn Kujawa; James E Swain; Kate D Fitzgerald; Christopher S Monk; K Luan Phan
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-06-24       Impact factor: 4.785

3.  Common Pitfalls in Exposure and Response Prevention (EX/RP) for OCD.

Authors:  Seth J Gillihan; Monnica T Williams; Emily Malcoun; Elna Yadin; Edna B Foa
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-05-30       Impact factor: 1.677

4.  The effect of a single-session attention modification program on response to a public-speaking challenge in socially anxious individuals.

Authors:  Nader Amir; Geri Weber; Courtney Beard; Jessica Bomyea; Charles T Taylor
Journal:  J Abnorm Psychol       Date:  2008-11

Review 5.  Biobehavioral assessment of the anxiety disorders: Current progress and future directions.

Authors:  Deah Abbott; Yasmin Shirali; J Kyle Haws; Caleb W Lack
Journal:  World J Psychiatry       Date:  2017-09-22

6.  Look at the Audience? A Randomized Controlled Study of Shifting Attention From Self-Focus to Nonsocial vs. Social External Stimuli During Virtual Reality Exposure to Public Speaking in Social Anxiety.

Authors:  Theresa F Wechsler; Michael Pfaller; Rahel E van Eickels; Luise H Schulz; Andreas Mühlberger
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.